Laryngoscope exposure glottis examination
Conditions
Interventions
Group1:Lidocaine atomized inhalation+saline I.V
G2:Lidocaine aerosol inhalation + dexmedetomidine intravenous infusion
G3:Inhalation of aerosol lidocaine + intravenous infusion of Nalbuphine hydrochloride
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients undergoing general anesthesia; 2.ASA grade ?-?; Mallampati classification was ?-?; The subjects voluntarily participated in the study and had signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Evidence of serious cardio-cerebrovascular, liver or kidney diseases, blood or liver diseases, sinus delay or cardiac transmission block; 2. Patients with suspected mask dyspnea, hypoxemia, and severe respiratory diseases; 3. Mouth opening meets laryngoscopy; 4. Local anesthetic allergy patients, dexmedetomidine, nalbuphine allergy, sufentanil citrate patients; 5. Patients with high risk of reflux aspiration, such as satiety, reflux esophagitis and intestinal obstruction; 6. Patients with coagulation dysfunction and hyperkalemia; 7. For any other reason, the researcher considers it inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tolerance score of awake laryngoscopy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea, pain, coughing;Airway assessment and glottic exposure assessment;Vital signs, including blood pressure, heart rate, oxygen saturation;patients' satisfaction and comfort degree;postoperative follow-up;Basic information of the patient, including age, sex, height and weight;Depth of sedation score; | — |
Countries
China
Contacts
Public ContactZhong Weiwei
Outcome results
None listed